Revised criteria for Alzheimer's disease: what are the lessons for clinicians?

被引：19
作者：
Frisoni, Giovanni B. [1 ]
Hampel, Harald [2 ]
O'Brien, John T. [3 ]
Ritchie, Karen [4 ,5 ]
Winblad, Bengt [6 ]
机构：
[1] Fatebenefratelli, Inst Recovero & Cura Carattere Sci, I-25125 Brescia, Italy
[2] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany
[3] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[4] INSERM, U1061, Montpellier, France
[5] Univ London Imperial Coll Sci Technol & Med, London, England
[6] Karolinska Inst, Alzheimer Dis Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden
来源：
LANCET NEUROLOGY | 2011年 / 10卷 / 07期
关键词：
ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RECOMMENDATIONS; BIOMARKERS;
D O I：
10.1016/S1474-4422(11)70126-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：598 / 601
页数：4
相关论文
共 50 条
  • [41] Use of Biomarkers in Ongoing Research Protocols on Alzheimer's Disease
    Canevelli, Marco
    Remoli, Giulia
    Bacigalupo, Ilaria
    Valletta, Martina
    Toccaceli Blasi, Marco
    Sciancalepore, Francesco
    Bruno, Giuseppe
    Cesari, Matteo
    Vanacore, Nicola
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (03): : 1 - 11
  • [42] Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuum
    Cervera-Carles, Laura
    Alcolea, Daniel
    Estanga, Ainara
    Ecay-Torres, Mirian
    Izagirre, Andrea
    Clerigue, Montserrat
    Garcia-Sebastian, Maite
    Villanua, Jorge
    Escalas, Claudia
    Blesa, Rafael
    Martinez-Lage, Pablo
    Lleo, Alberto
    Fortea, Juan
    Clarimon, Jordi
    NEUROBIOLOGY OF AGING, 2017, 53 : 192.e1 - 192.e4
  • [43] Alzheimer's disease and the development of a post-genomic science
    Milne, Richard
    Latimer, Joanna
    NEW GENETICS AND SOCIETY, 2020, 39 (01) : 1 - 12
  • [44] Modifying the minimum criteria for diagnosing amnestic MCI to improve prediction of brain atrophy and progression to Alzheimer's disease
    Vuoksimaa, Eero
    McEvoy, Linda K.
    Holland, Dominic
    Franz, Carol E.
    Kremen, William S.
    BRAIN IMAGING AND BEHAVIOR, 2020, 14 (03) : 787 - 796
  • [45] Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI
    Wang, Hui-Fu
    Tan, Lan
    Cao, Lei
    Zhu, Xi-Chen
    Jiang, Teng
    Tan, Meng-Shan
    Liu, Ying
    Wang, Chong
    Tsai, Richard M.
    Jia, Jian-Ping
    Yu, Jin-Tai
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (01) : 227 - 236
  • [46] Biomarkers for the Diagnosis of Alzheimer's Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
    Dulewicz, Maciej
    Kulczynska-Przybik, Agnieszka
    Mroczko, Piotr
    Kornhuber, Johannes
    Lewczuk, Piotr
    Mroczko, Barbara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [47] Neuroimaging Results Impose New Views on Alzheimer's Disease-the Role of Amyloid Revised
    Fjell, Anders M.
    Walhovd, Kristine B.
    MOLECULAR NEUROBIOLOGY, 2012, 45 (01) : 153 - 172
  • [48] Alzheimer's disease biomarkers Reply
    Chu, L. W.
    HONG KONG MEDICAL JOURNAL, 2012, 18 (04) : 352 - 352
  • [49] Metabolomics in Alzheimer's disease research
    Ibanez, Clara
    Simo, Carolina
    Cifuentes, Alejandro
    ELECTROPHORESIS, 2013, 34 (19) : 2799 - 2811
  • [50] Lecanemab in Early Alzheimer's Disease
    van Dyck, Christopher H.
    Swanson, Chad J.
    Aisen, Paul
    Bateman, Randall J.
    Chen, Christopher
    Gee, Michelle
    Kanekiyo, Michio
    Li, David
    Reyderman, Larisa
    Cohen, Sharon
    Froelich, Lutz
    Katayama, Sadao
    Sabbagh, Marwan
    Vellas, Bruno
    Watson, David
    Dhadda, Shobha
    Irizarry, Michael
    Kramer, Lynn D.
    Iwatsubo, Takeshi
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (01) : 9 - 21
12345